Page 2 - Halberd Corp News Today

JACKSON CENTER, PA / ACCESSWIRE / May 19, 2021 / Halberd Corporation (OTC PINK:HALB) was featured in a recent MarketWatch article, "New Approaches to Covid-19 Treatment Enter the Picture," along with six other notable biotechnology companies. As stated in the article, "The Covid-19 treatment response process includes a number of different major players, including Pfizer Inc (PFE), BioNTech SE - ADR (BNTX), Moderna Inc (MRNA), AstraZeneca plc (NAZN), Novavax Inc (NVAX), Halberd Corp (OTC PINK:H...

"MarketWatch" Features Halberd Corporation With Prominent Pharmaceutical Companies on New Treatments for COVID-19 ACCESSWIRE 19 May 2021, 22:05 GMT+10 JACKSON CENTER, PA / ACCESSWIRE / May 19, 2021 / Halberd Corporation (OTC PINK:HALB) was featured in a recent MarketWatch article, New Approaches to Covid-19 Treatment Enter the Picture, along with six other notable biotechnology companies. As stated in the article, The Covid-19 treatment response process includes a number of different major pla...

Halberd Corporation Starts VITA-SHIELD-MAX Immunity Boosting Nutraceutical Production JACKSON CENTER, PA / ACCESSWIRE / March 16, 2021 / Halberd Corporation (OTC PINK:HALB) has contracted with a major nutraceutical manufacturer to produce its initial production lot of Halberds VITA-SHIELD-MAX TM Immune Booster. Halberds scientists designed this proprietary combination of vitamins and minerals to help the body increase its natural immunity and promote general health. Dr. Patricio Reyes, Halberd ...

JACKSON CENTER, PA / ACCESSWIRE / March 11, 2021 / Halberd Corporation (OTC PINK:HALB) has filed for trademark protection for the name VITA-SHIELD-MAXTM for its proprietary blend of over-the-counter nutraceuticals

JACKSON CENTER, PA / ACCESSWIRE / March 2, 2021 / Halberd Corp. (OTC PINK:HALB) has recently produced a proprietary monoclonal antibody that has at least 20 times greater neutralizing affinity than their

JACKSON CENTER, PA / ACCESSWIRE / February 16, 2021 / Halberd Corp. (OTC PINK:HALB) has engaged GreenBioAZ, Inc. to conduct laboratory testing of Halberd's patent pending Radio Frequency (RF) extracorporeal

JACKSON CENTER, PA / ACCESSWIRE / January 14, 2021 / Halberd Corp. (OTC PINK:HALB) announced the filing of a provisional patent application on a proprietary combination of nutritional supplements (melatonin

JACKSON CENTER, PA / ACCESSWIRE / January 12, 2021 / Halberd Corp. (OTC PINK:HALB) was recently included alongside Novavax Inc and Moderna Inc in a recent Wall Street PR article on Covid-19 related stocks